CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 36 enrolled
Drug / intervention
Expareldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02586077
NCT02586077Phase 4Completed
CompareCT.gov

Foot and Ankle Clinic Application for Liposomal Related Anesthetic

OrthoCarolina Research Institute, Inc.·interventional·Posted Oct 26, 2015·Updated Oct 29, 2020

In Brief

A Phase 4 clinical trial evaluating Exparel for Ankle Arthrodesis and 2 related conditions. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The purpose of this study is to review the use of surgeon applied liposomal release anesthetic (Exparel) for post operative analgesia. Hypothesis: Surgeon applied use of liposomal related anesthetic provides excellent post operative analgesia. Immediated and 72 hour narcotic use will be significantly impacted by the use of this modality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnkle Arthrodesis, Hindfoot Arthrodesis, Tibitalocalceal Arthrodesis
CountriesUnited States
CollaboratorsPacira Pharmaceuticals, Inc

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 26, 2015
Enrollment StartFeb 1, 2014
Primary CompletionJun 30, 2016
Study CompletionNov 15, 2016
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.7 years ago

Interventions

Expareldrug